Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Adipose-targeted SWELL1 deletion exacerbates obesity- and age-related nonalcoholic fatty liver disease
Susheel K. Gunasekar, John Heebink, Danielle H. Carpenter, Ashutosh Kumar, Litao Xie, Haixia Zhang, Joel D. Schilling, Rajan Sah
Susheel K. Gunasekar, John Heebink, Danielle H. Carpenter, Ashutosh Kumar, Litao Xie, Haixia Zhang, Joel D. Schilling, Rajan Sah
View: Text | PDF
Research Article Hepatology Metabolism

Adipose-targeted SWELL1 deletion exacerbates obesity- and age-related nonalcoholic fatty liver disease

  • Text
  • PDF
Abstract

Healthy expansion of adipose tissue is critical for the maintenance of metabolic health, providing an optimized reservoir for energy storage in the form of triacylglycerol-rich lipoproteins. Dysfunctional adipocytes that are unable to efficiently store lipid can result in lipodystrophy and contribute to nonalcoholic fatty liver disease (NAFLD) and metabolic syndrome. Leucine-rich repeat containing protein 8a/SWELL1 functionally encodes the volume-regulated anion channel complex in adipocytes, is induced in early obesity, and is required for normal adipocyte expansion during high-fat feeding. Adipose-specific SWELL1 ablation (Adipo KO) leads to insulin resistance and hyperglycemia during caloric excess, both of which are associated with NAFLD. Here, we show that Adipo-KO mice exhibited impaired adipose depot expansion and excess lipolysis when raised on a variety of high-fat diets, resulting in increased diacylglycerides and hepatic steatosis, thereby driving liver injury. Liver lipidomic analysis revealed increases in oleic acid–containing hepatic triacylglycerides and injurious hepatic diacylglyceride species, with reductions in hepatocyte-protective phospholipids and antiinflammatory free fatty acids. Aged Adipo-KO mice developed hepatic steatosis on a regular chow diet, and Adipo-KO male mice developed spontaneous, aggressive hepatocellular carcinomas (HCCs). These data highlight the importance of adipocyte SWELL1 for healthy adipocyte expansion to protect against NAFLD and HCC in the setting of overnutrition and with aging.

Authors

Susheel K. Gunasekar, John Heebink, Danielle H. Carpenter, Ashutosh Kumar, Litao Xie, Haixia Zhang, Joel D. Schilling, Rajan Sah

×

Figure 2

Adipose SWELL1 ablation augments lipolysis and hormone sensitive lipase activation.

Options: View larger image (or click on image) Download as PowerPoint
Adipose SWELL1 ablation augments lipolysis and hormone sensitive lipase ...
(A) Percentage decrease in total fat in high-fat (HF) diet (6–9 months) WT and Adipo-KO mice (males) after switching to regular chow (RC) diet for 4 weeks estimated by NMR. (B) Total body weight of WT (n = 7) and Adipo-KO (n = 8) mice (males) fed with GAN diet for 22 weeks. (C) Body composition for total fat and lean mass estimated by EchoMRI from mice in B at 22-week time point of GAN diet. (D) Random plasma NEFAs and glycerol normalized to total fat mass of WT and Adipo-KO mice in B. (E) mRNA expression of CD36 and PLIN relative to GAPDH in eWAT isolated from WT and Adipo-KO (n = 8 each, males) mice on GAN diet for 22–25 weeks. (F and G) Ex vivo lipolysis assay measuring NEFA (F) and glycerol (G) released from eWAT of WT (n = 9 experimental replicates from 3 mice) and Adipo-KO mice (n = 8 experimental replicates from 3 mice) at 30, 60, 90, and 120 minutes under basal, unstimulated conditions. (H and I) Ex vivo lipolysis assay measuring NEFA (H) released from WT and Adipo-KO (n = 11–12 experimental replicates from 2 mice/group) mice on HFD for 5 weeks at 30, 60, 90, and 120 minutes upon stimulation with 50 nM isoproterenol and the corresponding rate of NEFA production (I). (J) Western blots for protein levels of SWELL1, p-HSL, total HSL, and β-actin from primary adipocytes isolated from SWELL1fl/fl mice transduced with either Ad-GFP or Ad-Cre-GFP to generate WT and SWELL1-KO primary adipocytes and treated with either vehicle or 100 nM isoproterenol for 15 minutes and the corresponding densitometry analysis. Data are represented as mean ± SEM. Two-tailed unpaired t test was used in A–E and I. Two-way ANOVA was used in F–H. One-way ANOVA was used in J. *, **, and *** represent P < 0.05, P < 0.01, and P < 0.001, respectively.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts